|
1
|
Fletcher CDM, Bridge JA, Hogendoorn PCW
and Mertens F: WHO Classification of Tumours of Soft Tissue and
Bone. 5. 4th edition. IARC; Lyon: 2013
|
|
2
|
Estil JCJ Jr, Yeo ED, Kim HJ, Cho WT and
Lee JJ: A large extraskeletal osteochondroma of the foot. J Foot
Ankle Surg. 52:663–665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kho VK and Chen WC: Extraskeletal
osteochondroma of the foot. J Chin Med Assoc. 73:52–55. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sit YK and Lui TH: Extraskeletal
osteochondroma of the medial arch of the foot. Foot Ankle Spec.
5:397–400. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bovée JV: EXTra hit for mouse
osteochondroma. Proc Natl Acad Sci USA. 107:1813–1814. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jones KB, Piombo V, Searby C, Kurriger G,
Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA,
Capecchi MR, et al: A mouse model of osteochondromagenesis from
clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci
USA. 107:2054–2059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hameetman L, David G, Yavas A, White SJ,
Taminiau AH, Cleton-Jansen AM, Hogendoorn PC and Bovée JV:
Decreased EXT expression and intracellular accumulation of heparan
sulphate proteoglycan in osteochondromas and peripheral
chon-drosarcomas. J Pathol. 211:399–409. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hameetman L, Szuhai K, Yavas A,
Knijnenburg J, van Duin M, van Dekken H, Taminiau AH, Cleton-Jansen
AM, Bovée JV and Hogendoorn PC: The role of EXT1 in nonhereditary
osteochondroma: identification of homozygous deletions. J Natl
Cancer Inst. 99:396–406. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Busse-Wicher M, Wicher KB and
Kusche-Gullberg M: The exostosin family: proteins with many
functions. Matrix Biol. 35:25–33. 2014. View Article : Google Scholar
|
|
10
|
McCormick C, Duncan G, Goutsos KT and
Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a
stable complex that accumulates in the Golgi apparatus and
catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA.
97:668–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huegel J, Sgariglia F, Enomoto-Iwamoto M,
Koyama E, Dormans JP and Pacifici M: Heparan sulfate in skeletal
development, growth, and pathology: the case of hereditary multiple
exostoses. Dev Dyn. 242:1021–1032. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maheshwari AV, Jain AK and Dhammi IK:
Extraskeletal para-articular osteochondroma of the knee - a case
report and tumor overview. Knee. 13:411–414. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maheshwari AV, Muro-Cacho CA and Pitcher
JD Jr: Extraskeletal para-articular osteochondroma of the posterior
knee. J Knee Surg. 22:30–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nogita T and Kawakami M: Extraskeletal
osteochondroma in the finger. Mimicking the fourth phalangeal bone.
Acta Derm Venereol. 72:287–288. 1992.PubMed/NCBI
|
|
15
|
Sheff JS and Wang S: Extraskeletal
osteochondroma of the foot. J Foot Ankle Surg. 44:57–59. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu ZJ, Zhao Q and Zhang LJ: Extraskeletal
osteochondroma near the hip: a pediatric case. J Pediatr Orthop B.
19:524–528. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lim SC, Kim YS, Kim YS and Moon YR:
Extraskeletal osteo-chondroma of the buttock. J Korean Med Sci.
18:127–130. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh R, Sharma AK, Magu NK, Kaur KP, Sen
R and Magu S: Extraskeletal osteochondroma in the nape of the neck:
a case report. J Orthop Surg (Hong Kong). 14:192–195. 2006.
|
|
19
|
Mandahl N: Methods in solid tumour
cytogenetics. Human Cytogenetics: Malignancy and Acquired
Abnormalities. Rooney DE: Oxford University Press; New York NY: pp.
165–203. 2001
|
|
20
|
Schaffer LG, Slovak ML and Campbell LJ:
ISCN 2009: An International System for Human Cytogenetic
Nomenclature. Karger, Basel: 2009
|
|
21
|
Song C, Zhou X, Dong Q, Fan R, Wu G, Ji B,
Meng Q and Zheng M: Regulation of inflammatory response in human
chondrocytes by lentiviral mediated RNA interference against
S100A10. Inflamm Res. 61:1219–1227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gorunova L, Bjerkehagen B and Heim S:
Paratesticular leiomyoma with a der(14)t(12;14)(q15;q24). Cancer
Genet. 204:465–468. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bridge JA, Bhatia PS, Anderson JR and Neff
JR: Biologic and clinical significance of cytogenetic and molecular
cytogenetic abnormalities in benign and malignant cartilaginous
lesions. Cancer Genet Cytogenet. 69:79–90. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bridge JA, Nelson M, Orndal C, Bhatia P
and Neff JR: Clonal karyotypic abnormalities of the hereditary
multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11–12
(EXT2) in patients with sporadic and hereditary osteochondromas.
Cancer. 82:1657–1663. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Buddingh EP, Naumann S, Nelson M, Neffa
JR, Birch N and Bridge JA: Cytogenetic findings in benign
cartilaginous neoplasms. Cancer Genet Cytogenet. 141:164–168. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feely MG, Boehm AK, Bridge RS, Krallman
PA, Neff JR, Nelson M and Bridge JA: Cytogenetic and molecular
cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma.
Cancer Genet Cytogenet. 137:102–107. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mertens F, Rydholm A, Kreicbergs A, Willén
H, Jonsson K, Heim S, Mitelman F and Mandahl N: Loss of chromosome
band 8q24 in sporadic osteocartilaginous exostoses. Genes
Chromosomes Cancer. 9:8–12. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sawyer JR, Swanson CM, Lukacs JL, Nicholas
RW, North PE and Thomas JR: Evidence of an association between
6q13–21 chromosome aberrations and locally aggressive behavior in
patients with cartilage tumors. Cancer. 82:474–483. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sawyer JR, Thomas EL, Lukacs JL, Swanson
CM, Ding Y, Parham DM, Thomas JR and Nicholas RW: Recurring
breakpoints of 1p13 approximately p22 in osteochondroma. Cancer
Genet Cytogenet. 138:102–106. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tallini G, Dorfman H, Brys P, Dal Cin P,
De Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Mitelman
F, et al: Correlation between clinicopathological features and
karyotype in 100 cartilaginous and chordoid tumours. A report from
the chromosomes and morphology (CHAMP) collaborative study Group. J
Pathol. 196:194–203. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heim S and Mitelman F: Cancer
Cytogenetics. 3rd edition. Wiley-Blackwell; New York, NY: 2009
|
|
32
|
Hauke S, Leopold S, Schlueter C, Flohr AM,
Murua Escobar H, Rogalla P and Bullerdiek J: Extensive expression
studies revealed a complex alternative splicing pattern of the
HMGA2 gene. Biochim Biophys Acta. 1729:24–31. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Quade BJ, Weremowicz S, Neskey DM, Vanni
R, Ladd C, Dal Cin P and Morton CC: Fusion transcripts involving
HMGA2 are not a common molecular mechanism in uterine leiomyomata
with rearrangements in 12q15. Cancer Res. 63:1351–1358.
2003.PubMed/NCBI
|
|
34
|
Cleynen I and Van de Ven WJ: The HMGA
proteins: A myriad of functions (Review). Int J Oncol. 32:289–305.
2008.PubMed/NCBI
|
|
35
|
Richter A, Hauschild G, Murua Escobar H,
Nolte I and Bullerdiek J: Application of high-mobility-group-A
proteins increases the proliferative activity of chondrocytes in
vitro. Tissue Eng Part A. 15:473–477. 2009. View Article : Google Scholar
|
|
36
|
Richter A, Lübbing M, Frank HG, Nolte I,
Bullerdiek JC and von Ahsen I: High-mobility group protein
HMGA2-derived fragments stimulate the proliferation of chondrocytes
and adipose tissue-derived stem cells. Eur Cell Mater. 21:355–363.
2011.PubMed/NCBI
|
|
37
|
Kubo T, Matsui Y, Goto T, Yukata K and
Yasui N: Overexpression of HMGA2-LPP fusion transcripts promotes
expression of the alpha 2 type XI collagen gene. Biochem Biophys
Res Commun. 340:476–481. 2006. View Article : Google Scholar
|
|
38
|
Dahlén A, Mertens F, Rydholm A, Brosjö O,
Wejde J, Mandahl N and Panagopoulos I: Fusion, disruption, and
expression of HMGA2 in bone and soft tissue chondromas. Mod Pathol.
16:1132–1140. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Panagopoulos I, Gorunova L, Taksdal I,
Bjerkehagen B and Heim S: Recurrent 12q13–15 chromosomal
aberrations, high frequency of isocitrate dehydrogenase 1
mutations, and absence of high mobility group AT-hook 2 expression
in periosteal chondromas. Oncol Lett. 10:163–167. 2015.
|
